E. Moreno

763 total citations
47 papers, 523 citations indexed

About

E. Moreno is a scholar working on Immunology, Hematology and Oncology. According to data from OpenAlex, E. Moreno has authored 47 papers receiving a total of 523 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Immunology, 12 papers in Hematology and 11 papers in Oncology. Recurrent topics in E. Moreno's work include T-cell and B-cell Immunology (15 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). E. Moreno is often cited by papers focused on T-cell and B-cell Immunology (15 papers), Immune Cell Function and Interaction (11 papers) and Immunotherapy and Immune Responses (8 papers). E. Moreno collaborates with scholars based in Spain, United Kingdom and Belgium. E. Moreno's co-authors include Carlos Vilches, M. Kreisler, Rosario de Pablo, Marí­a José Herrero, Rodrigo Martino, Camille Azar, Μ. Cremer, Jorge Sierra, Michel Baize and Jacques Devière and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

E. Moreno

43 papers receiving 506 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Moreno Spain 11 247 132 125 120 42 47 523
U. Gross‐Wieltsch Germany 7 262 1.1× 361 2.7× 53 0.4× 101 0.8× 21 0.5× 9 540
S.M. Liesenfeld Germany 5 260 1.1× 353 2.7× 45 0.4× 82 0.7× 49 1.2× 6 522
Jean‐Marc Doutrelepont Belgium 11 241 1.0× 105 0.8× 41 0.3× 56 0.5× 31 0.7× 18 451
A Rosenmayr Austria 10 256 1.0× 374 2.8× 52 0.4× 97 0.8× 36 0.9× 20 522
Viki Anders United States 11 259 1.0× 489 3.7× 59 0.5× 97 0.8× 55 1.3× 12 622
Cristina Skert Italy 14 188 0.8× 392 3.0× 73 0.6× 118 1.0× 103 2.5× 21 559
Birte Wistinghausen United States 11 291 1.2× 266 2.0× 59 0.5× 293 2.4× 15 0.4× 29 705
Nan Young Lee South Korea 14 176 0.7× 306 2.3× 33 0.3× 174 1.4× 23 0.5× 41 545
Jesse Levin United States 4 296 1.2× 449 3.4× 29 0.2× 111 0.9× 31 0.7× 6 558
Aude Marie‐Cardine France 9 112 0.5× 137 1.0× 34 0.3× 73 0.6× 68 1.6× 24 414

Countries citing papers authored by E. Moreno

Since Specialization
Citations

This map shows the geographic impact of E. Moreno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Moreno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Moreno more than expected).

Fields of papers citing papers by E. Moreno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Moreno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Moreno. The network helps show where E. Moreno may publish in the future.

Co-authorship network of co-authors of E. Moreno

This figure shows the co-authorship network connecting the top 25 collaborators of E. Moreno. A scholar is included among the top collaborators of E. Moreno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Moreno. E. Moreno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santaballa, Ana, et al.. (2025). Sex-related differences in the efficacy and toxicity of cancer treatments. Clinical & Translational Oncology. 27(9). 3636–3646. 1 indexed citations
2.
Higuera, Oliver, et al.. (2025). Sex and gender differences in cancer pathogenesis and pharmacology. Clinical & Translational Oncology. 27(10). 3837–3848. 4 indexed citations
3.
Caballero, A, Irene García‐Cadenas, Albert Esquirol, et al.. (2025). HSP-CAR30 with a high proportion of less-differentiated T cells promotes durable responses in refractory CD30+ lymphoma. Blood. 145(16). 1788–1801.
4.
5.
Moreno, E., et al.. (2025). Therapeutic drug monitoring of linezolid in a case of pulmonary nocardiosis: a case report. European Journal of Hospital Pharmacy. ejhpharm–2024.
6.
Nezvalová‐Henriksen, Kateřina, E. Moreno, Nicolaus Kröger, et al.. (2024). A practical guide to therapeutic drug monitoring in busulfan: recommendations from the Pharmacist Committee of the European Society for Blood and Marrow Transplantation (EBMT). Bone Marrow Transplantation. 59(12). 1641–1653. 3 indexed citations
7.
Jiménez, Silvia, Inmaculada Mora-Jiménez, Margarita Garrido, et al.. (2024). First-line pembrolizumab for lung cancer in a Spanish real-world study.. Journal of Clinical Oncology. 42(16_suppl). e23268–e23268. 1 indexed citations
8.
Moreno, E., et al.. (2023). Feasibility of a New Model of Care for Allogeneic Stem Cell Transplantation Recipients Facilitated by eHealth: The MY-Medula Pilot Study. Transplantation and Cellular Therapy. 29(6). 385.e1–385.e8. 5 indexed citations
9.
Nezvalová‐Henriksen, Kateřina, Claudia Langebrake, Tiene Bauters, et al.. (2023). Implementation and operational management of marketed chimeric antigen receptor T cell (CAR-T Cell) therapy—a guidance by the GoCART Coalition Pharmacist Working Group. Bone Marrow Transplantation. 58(10). 1069–1074. 5 indexed citations
10.
Moreno, E., et al.. (2022). Educación, historia reciente y memoria: Investigaciones y aproximaciones metodológicas. Orientación y Sociedad. 1 indexed citations
11.
Albanell, Joan, et al.. (2020). PCN78 Costs of Recurrence in Patients with HER2+ Breast Cancer in Spain. Value in Health. 23. S435–S435. 1 indexed citations
12.
Crespo, Carlos, et al.. (2013). Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain. Health Economics Review. 3(1). 28–28. 8 indexed citations
13.
Delgado, Julio, E. Moreno, José Luís Piñana, et al.. (2009). Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen. Cytotherapy. 11(3). 356–361. 3 indexed citations
14.
Piñana, José Luís, David Valcárcel, Rodrigo Martino, et al.. (2009). Study of Kidney Function Impairment after Reduced-Intensity Conditioning Allogeneic Hematopoietic Stem Cell Transplantation. A Single-Center Experience. Biology of Blood and Marrow Transplantation. 15(1). 21–29. 41 indexed citations
15.
Estefanía, E., Natalia Gómez‐Lozano, Rosario de Pablo, E. Moreno, & Carlos Vilches. (2002). Complementary DNA sequence of the novel HLA‐B*3704 allele. Tissue Antigens. 59(2). 142–144. 8 indexed citations
16.
Vilches, Carlos, Laura Sanz, Rosario de Pablo, et al.. (1996). Molecular characterization of the new alleles HLA‐B*8101 and B*4407. Tissue Antigens. 47(2). 139–142. 26 indexed citations
17.
Devière, Jacques, Michel Baize, Camille Azar, et al.. (1995). Complete disruption of the main pancreatic duct: Endoscopic management. Gastrointestinal Endoscopy. 42(5). 445–451. 98 indexed citations
18.
Vilches, Carlos, Marí­a José Herrero, Rosario de Pablo, et al.. (1994). Molecular characterization of a novel, serologically detectable, HLA-C allele: Cw∗1602. Human Immunology. 41(2). 167–170. 15 indexed citations
19.
Pablo, Rosario de, et al.. (1992). Distribution of HLA antigens in Spanish Gypsies: A comparative study. Tissue Antigens. 40(4). 187–196. 35 indexed citations
20.
Moreno, E., et al.. (1991). Efecto del almacenamiento hermético en la calidad del maíz para tortillas. Turrialba. 41(4). 528–533. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by U. Gross‐Wieltsch Breakdown of academic impact, for papers by S.M. Liesenfeld Breakdown of academic impact, for papers by Jean‐Marc Doutrelepont Breakdown of academic impact, for papers by A Rosenmayr Breakdown of academic impact, for papers by Viki Anders Breakdown of academic impact, for papers by Cristina Skert Breakdown of academic impact, for papers by Birte Wistinghausen Breakdown of academic impact, for papers by Nan Young Lee Breakdown of academic impact, for papers by Jesse Levin Breakdown of academic impact, for papers by Aude Marie‐Cardine
Rankless by CCL
2026